距骨软骨损伤的治疗指南基于低质量和低水平的证据。因此,召集了一个国际共识专家组,以就距骨软骨损伤的关键主题达成共识。这篇共识文章的目的是解释这一过程,并描述这次共识会议得出的关于使用“自体骨软骨移植”治疗距骨软骨损伤的共识声明。
代表25个国家和1个地区的75名踝关节软骨修复国际专家召集并参与了一个基于德尔菲法达成共识的过程。在11个工作组中起草了问题和声明,重点是踝关节软骨修复中的特定主题。之后,我们进行了全面的文献综述,并对每个陈述的现有证据进行分级.讨论和辩论是在工作组内没有以一致方式商定发言的情况下进行的。随后进行了最后投票,共识的强度如下:共识,51%至74%;强烈共识,75%至99%;一致,100%。
在2017年踝关节软骨修复国际共识会议期间,共有14项关于自体骨软骨移植的声明达成共识。两个获得一致支持,11达成强烈共识(超过75%的协议),1、达成共识。所有声明达成至少67%的一致。
这项来自该领域领导者的国际共识将帮助临床医生将自体骨软骨移植作为距骨骨软骨损伤的治疗策略。
Treatment
guidelines for cartilage lesions of the talus have been based on both low quality and low levels of evidence. Therefore, an international consensus group of experts was convened to collaboratively advance toward consensus opinions on key topics regarding cartilage lesions of the talus. The purpose of this consensus article is to explain the process and delineate the consensus statements derived from this
consensus meeting on the use of \"osteochondral
autograft\" for osteochondral lesions of the talus.
Seventy-five international experts in cartilage repair of the ankle representing 25 countries and 1 territory were convened and participated in a process based on the Delphi method of achieving
consensus. Questions and statements were drafted within 11 working groups focusing on specific topics within cartilage repair of the ankle, after which a comprehensive literature review was performed and the available evidence for each statement was graded. Discussion and debate occurred in cases where statements were not agreed upon in unanimous fashion within the working groups. A final vote was then held, and the strength of consensus was characterized as follows: consensus, 51% to 74%; strong consensus, 75% to 99%; and unanimous, 100%.
A total of 14 statements on osteochondral
autograft reached
consensus during the 2017 International Consensus Meeting on Cartilage Repair of the Ankle. Two achieved unanimous support, 11 reached strong consensus (greater than 75% agreement), and 1 achieved
consensus. All statements reached at least 67% agreement.
This international consensus derived from leaders in the field will assist clinicians with osteochondral
autograft as a treatment strategy for osteochondral lesions of the talus.